npj Women's Health, Published online: 03 September 2026; doi:10.1038/s44294-026-00165-4 AI-derived cardiotocography age as a digital biomarker for predicting future adverse pregnancy outcomes
Jinshuai Gu, Zenghui Lin, Jingying Ma, Jingyu Wang, Linyan Zhang, Rui Bai et al. AI-derived cardiotocography age as a digital biomarker for predicting future adverse pregnancy outcomes. // npj Women's Health. – 2026. – DOI: 10.1038/s44294-026-00165-4. – URL: https://www.nature.com/articles/s44294-026-00165-4
Jinshuai Gu, Zenghui Lin, Jingying Ma, Jingyu Wang, Linyan Zhang, Rui Bai, Zelin Tu, Youyou Jiang, Donglin Xie, Yuxi Zhou, Guoli Liu, & Shenda Hong (2026). AI-derived cardiotocography age as a digital biomarker for predicting future adverse pregnancy outcomes. npj Women's Health. https://doi.org/10.1038/s44294-026-00165-4
Jinshuai Gu, et al. “AI-derived cardiotocography age as a digital biomarker for predicting future adverse pregnancy outcomes.” npj Women's Health, 2026. doi:10.1038/s44294-026-00165-4.
@article{Gu2026,
title = {AI-derived cardiotocography age as a digital biomarker for predicting future adverse pregnancy outcomes},
author = {Gu, Jinshuai and Lin, Zenghui and Ma, Jingying and Wang, Jingyu and Zhang, Linyan and Bai, Rui and Tu, Zelin and Jiang, Youyou and Xie, Donglin and Zhou, Yuxi and Liu, Guoli and Hong, Shenda},
journal = {npj Women's Health},
year = {2026},
doi = {10.1038/s44294-026-00165-4},
url = {https://www.nature.com/articles/s44294-026-00165-4}
}
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05030-x Comment on: ‘Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidence’
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05032-9 NAION during incretin-based therapy: an optic nerve head still adapted to hypertension
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05016-9 Comparing refractive errors in CACNA1F and CABP4 -associated disease in a UK cohort
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05018-7 Comment on: ‘Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease’